Latest Period
Q1 2026
Security Snapshot
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) Institutional Ownership
CUSIP: 74587B101
13F Institutional Holders and Ownership History from Q2 2016 to Q1 2026
Institutions Reporting
95
Shares (Excl. Options)
7,767,398
Price
$21.59
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- PLSE on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 7,767,398
- Total 13F value
- $167,599,169
- Portfolio coverage rank
- 0%
- Share change
- +1,448,473
- Value change
- +$32,826,415
- Number of holders
- 95
- Shares outstanding
- 69,132,716
- SEC-reported price per share
- $23.96
- Insider filing price
- $23.96
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PLSE - PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 74587B101.
- 95 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 79 to 95 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $86,895,531 to $167,599,169.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 95 institutions filings for Q1 2026.
Security key
74587B101
Latest holder period
Q1 2026
13F holders
95
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
PLSE full holder history
PULSE BIOSCIENCES, INC. SEC filings
PULSE BIOSCIENCES, INC. company facts
PULSE BIOSCIENCES, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74587B101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
PLSE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | 72% | +1.8% | $928,018,917 | +$17,066,023 | 49,706,423 | +1.9% | ROBERT W. DUGGAN | 11 May 2026 |
As of 31 Mar 2026, 95 institutional investors reported holding 7,767,398 shares of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE). This represents 11% of the company’s total 69,132,716 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
10%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1.9% | 1,339,778 | -1.3% | 0% | $28,925,807 |
| BANK OF AMERICA CORP /DE/ | 1.3% | 866,061 | +8.2% | 0% | $18,698,257 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2% | 815,852 | 0% | 0% | $17,614,245 |
| Portolan Capital Management, LLC | 1.1% | 733,372 | +86% | 0.84% | $15,833,501 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.71% | 491,946 | +5.9% | 0% | $10,623,020 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.67% | 462,899 | 0% | $9,993,989 | |
| STATE STREET CORP | 0.66% | 456,927 | +2.2% | 0% | $9,865,054 |
| Balyasny Asset Management L.P. | 0.38% | 265,164 | 0.01% | $5,724,891 | |
| GRIFFIN ASSET MANAGEMENT, INC. | 0.33% | 225,177 | -0.5% | 0.55% | $4,861,571 |
| LMR Partners LLP | 0.31% | 213,137 | 0.04% | $4,601,628 | |
| NORTHERN TRUST CORP | 0.27% | 187,272 | +1.6% | 0% | $4,043,202 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.24% | 165,201 | 0% | 0% | $3,566,690 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 147,768 | -3.1% | 0% | $3,190,311 |
| CITADEL ADVISORS LLC | 0.21% | 142,150 | +242% | 0% | $3,069,019 |
| VANGUARD FIDUCIARY TRUST CO | 0.19% | 130,606 | 0% | 0% | $2,819,784 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.12% | 81,252 | 0% | $1,754,231 | |
| Westside Investment Management, Inc. | 0.1% | 70,492 | +6.3% | 0.23% | $1,521,923 |
| Panoramic Capital, LLC | 0.08% | 58,054 | +53% | 0.88% | $1,253,386 |
| MILLENNIUM MANAGEMENT LLC | 0.08% | 55,817 | 0% | $1,205,089 | |
| Parkman Healthcare Partners LLC | 0.07% | 50,125 | 0.11% | $1,082,199 | |
| Nuveen, LLC | 0.07% | 45,435 | -5.7% | 0% | $980,942 |
| MORGAN STANLEY | 0.06% | 43,165 | +1.8% | 0% | $931,932 |
| Swiss National Bank | 0.06% | 39,100 | 0% | 0% | $844,169 |
| Bank of New York Mellon Corp | 0.06% | 38,477 | -0.21% | 0% | $830,720 |
| UBS Group AG | 0.05% | 33,954 | -55% | 0% | $733,066 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
40
Latest
Q1 2026
Rows shown
1-25 of 40
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 7,767,398 | $167,599,169 | +$32,826,415 | $21.59 | 95 |
| 2025 Q4 | 6,324,753 | $86,895,531 | +$5,802,737 | $13.73 | 79 |
| 2025 Q3 | 5,847,549 | $103,501,776 | -$2,129,619 | $17.70 | 82 |
| 2025 Q2 | 5,984,466 | $90,308,611 | +$4,349,324 | $15.09 | 85 |
| 2025 Q1 | 5,678,459 | $91,367,899 | -$5,798,556 | $16.09 | 82 |
| 2024 Q4 | 5,966,828 | $103,883,896 | +$5,132,130 | $17.41 | 71 |
| 2024 Q3 | 5,612,248 | $98,415,057 | +$11,001,269 | $17.54 | 70 |
| 2024 Q2 | 4,831,221 | $54,060,056 | +$1,064,725 | $11.19 | 56 |
| 2024 Q1 | 4,757,094 | $41,427,267 | +$2,924,385 | $8.71 | 60 |
| 2023 Q4 | 4,336,775 | $53,078,602 | +$7,954,945 | $12.24 | 49 |
| 2023 Q3 | 3,863,247 | $15,567,515 | +$685,290 | $4.03 | 43 |
| 2023 Q2 | 3,635,816 | $26,140,542 | +$8,715,301 | $7.19 | 45 |
| 2023 Q1 | 2,354,366 | $7,910,339 | -$336,779 | $3.36 | 24 |
| 2022 Q4 | 2,458,733 | $6,808,837 | +$269,595 | $2.77 | 26 |
| 2022 Q3 | 2,441,628 | $5,607,741 | -$1,322,192 | $2.30 | 26 |
| 2022 Q2 | 3,040,557 | $4,651,369 | -$3,031,805 | $1.53 | 35 |
| 2022 Q1 | 4,220,419 | $20,520,031 | -$3,953,330 | $4.86 | 52 |
| 2021 Q4 | 4,070,521 | $60,342,400 | -$1,060,254 | $14.81 | 47 |
| 2021 Q3 | 4,110,258 | $88,855,150 | +$21,153,376 | $21.60 | 54 |
| 2021 Q2 | 3,148,929 | $51,646,286 | -$3,190,258 | $16.40 | 53 |
| 2021 Q1 | 3,247,972 | $76,908,396 | +$4,719,921 | $23.68 | 56 |
| 2020 Q4 | 3,048,395 | $72,742,825 | +$3,484,917 | $23.86 | 53 |
| 2020 Q3 | 2,889,978 | $34,070,968 | -$377,193 | $11.79 | 44 |
| 2020 Q2 | 2,930,400 | $30,649,075 | +$7,653,890 | $10.46 | 49 |
| 2020 Q1 | 2,205,428 | $15,786,060 | -$304,466 | $7.16 | 44 |